Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996 Jan 04; 334(1):1-6.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Combined Modality Therapy
Cyclophosphamide
Disease-Free Survival
Female
Humans
Middle Aged
Neoplasm Staging
Neutropenia
Ovarian Neoplasms
Paclitaxel
Prospective Studies
Survival Analysis

authors with profiles

Michael H. Davidson